Given that venetoclax is a well‐established Bcl‐2 inhibitor, we thereafter performed western blot analysis of Bcl‐2 protein levels in parental cells, venetoclax‐resistant cells and MM cells with LAPTM5 overexpression. This evidence concerns the gene LAPTM5 and Miyoshi myopathy.